Bare metal stent

DEVICE20 trials

Sponsors

Antwerp Cardiovascular Institute Middelheim, Boston Scientific Corporation, Cardiovascular Research Foundation, New York, Heart Centre Rotenburg, University Hospital, Basel, Switzerland

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionAtherosclerosisChronic Total Occlusion of Artery of the ExtremitiesCoronary Artery DiseaseCoronary StenosisDiabetes MellitusHypertension, Portal

Phase 2

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

CompletedNCT00263263

Antwerp Cardiovascular Institute MiddelheimCoronary Artery Disease, Saphenous Vein Graft Disease, Stable Angina +1

Start: 2003-09-30End: 2005-12-31Target: 75Updated: 2007-03-14

Paclitaxel Eluting Balloon Versus Drug Eluting Stent in Native Coronary Artery Stenoses of Diabetic Patients

CompletedNCT00462631

Heart Centre RotenburgCoronary Stenosis, Diabetes Mellitus

Start: 2007-05-31End: 2016-02-29Updated: 2016-02-19

Drug-eluting Balloon in Acute Myocardial Infarction

CompletedNCT00856765

UMC UtrechtAcute Myocardial Infarction, Atherosclerosis, Coronary Artery Disease +1

Start: 2009-03-31End: 2016-11-30Updated: 2017-05-02

Phase 3

Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction

CompletedNCT00433966

Cardiovascular Research Foundation, New YorkMyocardial Infarction

Start: 2005-03-31End: 2010-11-30Updated: 2017-12-04

A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus

CompletedNCT01093391

Scitech Produtos Medicos LtdaCoronary Artery Disease

Start: 2010-11-30End: 2015-07-31Updated: 2015-07-22

Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction

CompletedNCT01839890

Francisco Javier GoicoleaAcute Myocardial Infarction

Start: 2012-04-30End: 2014-06-30Updated: 2015-02-06

Phase 4

Study to Test the Efficacy and Safety of Drug Eluting vs. Bare-Metal Stents for Saphenous Vein Graft Interventions

TerminatedNCT00595647

University Hospital, Basel, SwitzerlandCoronary Artery Disease

Start: 2008-02-29End: 2014-03-31Updated: 2015-04-21

Cost-Effectiveness Study in the Reduction of Coronary Restenosis With Sirolimus-Eluting Stents

CompletedNCT00627900

Charite University, Berlin, GermanyCoronary Artery Disease

Start: 2003-04-30Updated: 2008-03-04

Sirolimus-Eluting Stent Versus Standard Stent in Diabetic

CompletedNCT00755443

Hospital San Carlos, MadridCoronary Artery Disease

Start: 2003-02-28End: 2005-12-31Updated: 2008-09-19

A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent

CompletedNCT00825279

Centro de estudios en Cardiologia IntervencionistaCoronary Artery Disease

Start: 2007-08-31End: 2009-08-31Updated: 2010-05-28

Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty

CompletedNCT01121224

VA Office of Research and DevelopmentSaphenous Vein Graft Atherosclerosis

Start: 2012-01-11End: 2016-12-31Updated: 2022-07-26

OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation

CompletedNCT02504307

Scitech Produtos Medicos LtdaCoronary Artery Disease

Start: 2015-07-31End: 2017-09-30Updated: 2018-08-14

Unknown Phase

Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts

CompletedNCT00283413

Boston Scientific CorporationSymptomatic Ischemic Saphenous Vein Graft Disease

Start: 2002-03-31End: 2009-03-31Updated: 2009-11-02

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

CompletedNCT01036048

Catholic University of the Sacred HeartSaphenous Vein Graft Disease

Start: 2009-05-31End: 2009-12-31Updated: 2009-12-21

Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS

CompletedNCT01543373

CID - Carbostent & Implantable DevicesNSTEMI, Stable Angina, Unstable Angina

Start: 2012-01-31End: 2014-04-30Updated: 2018-04-30

Soluble Receptors for Advanced Glycation End-Products and PCI

University of SaskatchewanAcute Coronary Syndrome

Start: 2013-03-31End: 2015-06-30Target: 30Updated: 2013-06-03

Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions

CompletedNCT02456402

Ulsan University HospitalStable Angina, Unstable Angina

Start: 2015-04-30End: 2016-10-31Updated: 2019-04-03

Interventional Radiology for the Treatment of Symptomatic Portal Hypertension in Patients With Cavernous Transformation of Portal Vein

Sun Yat-sen UniversityHypertension, Portal, Portal Vein, Cavernous Transformation Of

Start: 2010-10-31Target: 150Updated: 2015-07-21

Drug Coated Balloon Versus Stenting in Patients With Symptomatic Vertebral Artery Stenosis：an Observational Clinical Study

CompletedNCT03311360

Chinese Society of Interventional RadiologyVertebral Artery Origin Stenosis

Start: 2018-01-01End: 2020-10-01Updated: 2021-08-03

Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents

TerminatedNCT03671655

North Texas Veterans Healthcare SystemChronic Total Occlusion of Artery of the Extremities, Peripheral Vascular Diseases

Start: 2014-01-31End: 2015-08-31Updated: 2018-09-14

Related Papers

Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

Cardiovascular Diagnosis and Therapy2023-10-017 citations

In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial).

2021-11-013 citations

Long‐Term Results After Drug‐Eluting Versus Bare‐Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial

Journal of the American Heart Association2020-10-099 citations

Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial.

2020-02-0514 citations

Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions

Coronary Artery Disease2019-04-2225 citations

Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial.

2018-05-1160 citations

Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS‐AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial

Journal of the American Heart Association2017-07-0118 citations

Effect of Short Procedural Duration With Bivalirudin on Increased Risk of Acute Stent Thrombosis in Patients With STEMI

JAMA Cardiology2017-03-017 citations

Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials

European Heart Journal Acute Cardiovascular Care2016-06-1023 citations

Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction

Circulation Cardiovascular Interventions2016-05-0116 citations

Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients

Circulation Cardiovascular Interventions2015-10-0157 citations

Four-year clinical follow-up of the first-in-man randomized comparison of a novel sirolimus eluting stent with abluminal biodegradable polymer and ultra-thin strut cobalt-chromium alloy: the INSPIRON-I trial.

2015-08-016 citations

Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes

Circulation Cardiovascular Interventions2015-07-22172 citations

Cerebrovascular Events After a Primary Percutaneous Coronary Intervention Strategy for Acute ST-Segment– Elevation Myocardial Infarction

Circulation Cardiovascular Interventions2015-04-015 citations

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

2015-01-0145 citations

Incidence, Predictors, and Implications of Reinfarction After Primary Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction

Circulation Cardiovascular Interventions2014-06-1886 citations

Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial).

2014-03-0111 citations

PT208 Bivalirudin versus Heparin alone in Primary PCI for ST-segment Elevation Myocardial Infarction

Global Heart2014-03-012 citations

Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.

2014-02-19361 citations

Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).

2014-01-3117 citations

26 more papers not shown